|
Insider Trading: INVITROGEN CORP
Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of INVITROGEN CORP in the last 24 months are illustrated in figures 1 and 2. Table 1 shows the monthly insider trading data of INVITROGEN CORP since year 2005. Table 2 shows the detailed insider transactions of INVITROGEN CORP since 2005.
The reporting company's ticker symbol is IVGN.
The reporting company's CIK number is 1073431.
The total value of stock buying since 2005 is $686,027.
The total value of stock sales is $113,208,459.
The total value of stock exercises is $40,984,746.
1 year stock price chart,
1 day stock price chart
opopp opopopop
Figure 1. Monthly insider transaction values at INVITROGEN CORP (IVGN) in the past 24 months.
The trade values of insider stock buys, sales, and option exercises are in logarithmic scale
as shown on the right axis labels.
The detailed monthly and daily insider transactions are listed in the 2 tables below.
08 09 10 11 12 01 2007 02 03 04 05 06 07 08 09 10 11 12 01 2008 02 03 04 05 06 07 -
Figure 2. Average prices of insider buys, sales, and option exercises at INVITROGEN CORP (IVGN) in the past 24 months. See table 2 for insider transaction details.
08 09 10 11 12 01 2007 02 03 04 05 06 07 08 09 10 11 12 01 2008 02 03 04 05 06 07 -
Table 1. Monthly summaries of insider stock purchases, sales, and option exercises
for INVITROGEN CORP (IVGN).
Trading Period
year-month |
Insider Buying
Shares Value ($) |
Insider Sales
Shares Value ($) |
Option Exercises
Shares Value ($) |
| 2008-07 | 0 | 0 | 0 | 0 | 40,000 | 0 |
| 2008-05 | 0 | 0 | 17,775 | 1,653,676 | 38,950 | 1,322,536 |
| 2008-04 | 0 | 0 | 9,450 | 865,824 | 8,883 | 0 |
| 2008-03 | 0 | 0 | 2,500 | 214,050 | 2,500 | 0 |
| 2008-02 | 0 | 0 | 29,771 | 2,603,075 | 42,096 | 2,176,929 |
| 2008-01 | 0 | 0 | 5,875 | 541,677 | 5,875 | 332,466 |
| 2007-12 | 0 | 0 | 482,877 | 46,702,731 | 302,487 | 14,296,742 |
| 2007-11 | 0 | 0 | 66,587 | 6,129,935 | 88,804 | 4,803,927 |
| 2007-10 | 0 | 0 | 432,104 | 37,699,828 | 292,000 | 10,338,144 |
| 2007-09 | 0 | 0 | 39,313 | 3,145,040 | 25,421 | 560,815 |
| 2007-08 | 0 | 0 | 23,587 | 1,848,625 | 400 | 28,944 |
| 2007-07 | 0 | 0 | 7,250 | 543,750 | 2,000 | 7,600 |
| 2007-06 | 0 | 0 | 23,822 | 1,766,539 | 17,550 | 696,650 |
| 2007-05 | 0 | 0 | 1,617 | 116,173 | 16,500 | 0 |
| 2007-02 | 0 | 0 | 105,035 | 6,949,583 | 109,135 | 6,299,993 |
| 2006-08 | 4,108 | 234,269 | 0 | 0 | 0 | 0 |
| 2006-06 | 100 | 6,326 | 0 | 0 | 0 | 0 |
| 2006-05 | 3,000 | 192,379 | 394 | 26,417 | 0 | 0 |
| 2006-03 | 0 | 0 | 5,000 | 348,634 | 0 | 0 |
| 2005-11 | 1,530 | 99,485 | 0 | 0 | 0 | 0 |
| 2005-08 | 0 | 0 | 262 | 22,382 | 0 | 0 |
| 2005-05 | 0 | 0 | 25,613 | 2,030,520 | 10,000 | 120,000 |
| 2005-03 | 1,000 | 71,080 | 0 | 0 | 0 | 0 |
| 2005-02 | 1,200 | 82,488 | 0 | 0 | 0 | 0 |
Table 2. Detailed insider stock purchases, sales, and option exercises
for INVITROGEN CORP (IVGN)
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2008-07-05 | Leddy Peter Michael (SVP, Human Resources) | Option Exercise | 40,000 | .00 | 0 |
| 2008-05-15 | Brust Bernd (SVP, Worldwide Sales) | Sale | 6,800 | 92.77 | 630,373 |
| 2008-05-15 | Brust Bernd (SVP, Worldwide Sales) | Option Exercise | 7,200 | 82.28 | 520,745 |
| 2008-05-13 | Brust Bernd (SVP - Worldwide Sales) | Option Exercise | 500 | .00 | 0 |
| 2008-05-13 | Hoffmeister David F (Chief Financial Officer) | Option Exercise | 4,500 | .00 | 0 |
| 2008-05-13 | Barthelemy Nicolas (SVP, Cell Culture Systems) | Option Exercise | 3,000 | .00 | 0 |
| 2008-05-13 | Benchimol Claude (SVP, Research & Development) | Option Exercise | 3,000 | .00 | 0 |
| 2008-05-13 | Lucier Gregory T (CEO) | Option Exercise | 6,000 | .00 | 0 |
| 2008-05-13 | Cottingham John A (SVP, Gen Counsel & Secretary) | Option Exercise | 1,500 | .00 | 0 |
| 2008-05-12 | Brust Bernd (SVP - Worldwide Sales) | Sale | 3,750 | 93.15 | 349,298 |
| 2008-05-12 | Brust Bernd (SVP - Worldwide Sales) | Option Exercise | 3,750 | 65.87 | 247,012 |
| 2008-05-01 | Short Jay M Phd (Director) | Sale | 2,500 | 94.60 | 236,487 |
| 2008-05-01 | Short Jay M Phd (Director) | Option Exercise | 2,500 | 21.04 | 52,600 |
| 2008-04-25 | Gibson Karen (Chief Information Officer) | Sale | 6,950 | 91.13 | 633,324 |
| 2008-04-25 | Gibson Karen (Chief Information Officer) | Option Exercise | 6,383 | .00 | 0 |
| 2008-04-23 | Barthelemy Nicolas (SVP, Cell Culture Systems) | Sale | 2,500 | 93.00 | 232,500 |
| 2008-04-23 | Barthelemy Nicolas (SVP, Cell Culture Systems) | Option Exercise | 2,500 | .00 | 0 |
| 2008-03-27 | Barthelemy Nicolas (SVP, Cell Culture Systems) | Sale | 2,500 | 85.62 | 214,050 |
| 2008-03-27 | Barthelemy Nicolas (SVP, Cell Culture Systems) | Option Exercise | 2,500 | .00 | 0 |
| 2008-02-27 | Gibson Karen (Chief Information Officer) | Sale | 14,250 | 87.00 | 1,239,750 |
| 2008-02-27 | Gibson Karen (Chief Information Officer) | Option Exercise | 14,250 | 63.51 | 905,017 |
| 2008-02-25 | Gibson Karen (Chief Information Officer) | Sale | 1,221 | 85.20 | 104,029 |
| 2008-02-19 | Uprichard David C (Director) | Sale | 200 | 86.69 | 17,338 |
| 2008-02-13 | Uprichard David C (Director) | Sale | 300 | 86.34 | 25,902 |
| 2008-02-08 | Short Jay M Phd (Director) | Sale | 13,800 | 88.12 | 1,216,056 |
| 2008-02-08 | Short Jay M Phd (Director) | Option Exercise | 27,846 | 45.68 | 1,271,912 |
| 2008-01-02 | Brust Bernd (SVP - Worldwide Sales) | Sale | 5,875 | 92.20 | 541,677 |
| 2008-01-02 | Brust Bernd (SVP - Worldwide Sales) | Option Exercise | 5,875 | 56.59 | 332,466 |
| 2007-12-17 | Hoffmeister David F (Chief Financial Officer) | Sale | 27,909 | 94.88 | 2,648,103 |
| 2007-12-13 | Uprichard David C (Director) | Sale | 2,100 | 94.68 | 198,828 |
| 2007-12-13 | Uprichard David C (Director) | Option Exercise | 2,100 | 72.36 | 151,956 |
| 2007-12-11 | Benchimol Claude (SVP, Research & Development) | Option Exercise | 6,804 | 58.76 | 399,803 |
| 2007-12-11 | Lucier Gregory T (CEO) | Sale | 65,676 | 94.32 | 6,209,927 |
| 2007-12-11 | Lucier Gregory T (CEO) | Option Exercise | 65,676 | 38.01 | 2,496,344 |
| 2007-12-10 | Lucier Gregory T (CEO) | Sale | 105,448 | 97.03 | 10,326,883 |
| 2007-12-10 | Lucier Gregory T (CEO) | Option Exercise | 105,648 | 38.01 | 4,015,680 |
| 2007-12-07 | Brust Bernd (SVP - Worldwide Sales) | Sale | 14,063 | 98.14 | 1,380,125 |
| 2007-12-07 | Brust Bernd (SVP - Worldwide Sales) | Option Exercise | 14,063 | 76.24 | 1,072,163 |
| 2007-12-06 | Benchimol Claude (SVP, Research & Development) | Sale | 108,186 | 97.48 | 10,545,430 |
| 2007-12-06 | Benchimol Claude (SVP, Research & Development) | Option Exercise | 93,196 | 58.76 | 5,476,196 |
| 2007-12-05 | Cottingham John A (SVP, Gen Counsel & Secretary) | Sale | 15,000 | 96.37 | 1,445,550 |
| 2007-12-05 | Cottingham John A (SVP, Gen Counsel & Secretary) | Option Exercise | 15,000 | 45.64 | 684,600 |
| 2007-11-30 | Brust Bernd (SVP - Worldwide Sales) | Sale | 5,625 | 96.54 | 543,065 |
| 2007-11-30 | Brust Bernd (SVP - Worldwide Sales) | Option Exercise | 5,625 | 65.94 | 370,912 |
| 2007-11-26 | Barthelemy Nicolas (SVP, Cell Culture Systems) | Sale | 13,579 | 95.00 | 1,290,005 |
| 2007-11-26 | Barthelemy Nicolas (SVP, Cell Culture Systems) | Option Exercise | 13,579 | 73.60 | 999,414 |
| 2007-11-19 | Benchimol Claude (SVP, Research & Development) | Sale | 1,031 | 91.40 | 94,233 |
| 2007-11-16 | Lucier Gregory T (CEO) | Sale | 400 | 90.07 | 36,028 |
| 2007-11-15 | Barthelemy Nicolas (SVP, Cell Culture Systems) | Sale | 1,031 | 90.61 | 93,418 |
| 2007-11-14 | Brust Bernd (SVP - Worldwide Sales) | Sale | 1,250 | 88.69 | 110,862 |
| 2007-11-14 | Brust Bernd (SVP - Worldwide Sales) | Option Exercise | 1,250 | 64.51 | 80,637 |
| 2007-11-14 | Barthelemy Nicolas (SVP, Cell Culture Systems) | Sale | 2,500 | 90.00 | 225,000 |
| 2007-11-14 | Barthelemy Nicolas (SVP, Cell Culture Systems) | Option Exercise | 2,500 | 64.51 | 161,275 |
| 2007-11-12 | Barthelemy Nicolas (SVP, Cell Culture Systems) | Sale | 3,250 | 90.00 | 292,500 |
| 2007-11-12 | Barthelemy Nicolas (SVP, Cell Culture Systems) | Option Exercise | 5,150 | 31.26 | 203,157 |
| 2007-11-12 | Gibson Karen (Chief Information Officer) | Option Exercise | 1,900 | .00 | 0 |
| 2007-11-12 | Benchimol Claude (SVP - R&D) | Option Exercise | 1,900 | .00 | 0 |
| 2007-11-12 | Lucier Gregory T (Chairman & CEO) | Option Exercise | 6,600 | .00 | 0 |
| 2007-11-12 | Cottingham John A (SVP, Gen Counsel & Secretary) | Option Exercise | 2,000 | .00 | 0 |
| 2007-11-07 | Grimm Donald W (Director) | Sale | 18,100 | 91.00 | 1,646,955 |
| 2007-11-07 | Grimm Donald W (Director) | Option Exercise | 21,900 | 79.33 | 1,514,198 |
| 2007-11-01 | Short Jay M Phd (Director) | Sale | 3,500 | 89.29 | 312,515 |
| 2007-11-01 | Short Jay M Phd (Director) | Option Exercise | 3,500 | 12.00 | 42,000 |
| 2007-10-31 | Barthelemy Nicolas (SVP, Cell Culture Systems) | Sale | 22,268 | 88.54 | 1,971,553 |
| 2007-10-31 | Barthelemy Nicolas (SVP, Cell Culture Systems) | Option Exercise | 22,268 | 66.92 | 1,490,285 |
| 2007-10-31 | Lucier Gregory T (Chairman & CEO) | Sale | 196,250 | 87.49 | 17,138,301 |
| 2007-10-31 | Lucier Gregory T (Chairman & CEO) | Option Exercise | 196,250 | 38.01 | 7,459,462 |
| 2007-10-25 | Barthelemy Nicolas (SVP, Cell Culture Systems) | Option Exercise | 2,842 | 70.34 | 199,906 |
| 2007-10-18 | Barthelemy Nicolas (SVP, Cell Culture Systems) | Sale | 5,640 | 84.52 | 476,692 |
| 2007-10-18 | Barthelemy Nicolas (SVP, Cell Culture Systems) | Option Exercise | 5,640 | 70.34 | 396,717 |
| 2007-10-18 | Lucier Gregory T (Chairman & CEO) | Sale | 3,750 | 85.00 | 318,750 |
| 2007-10-18 | Lucier Gregory T (Chairman & CEO) | Option Exercise | 3,750 | 38.01 | 142,537 |
| 2007-10-18 | Cottingham John A (SVP, Gen Counsel & Secretary) | Sale | 10,000 | 84.52 | 845,200 |
| 2007-10-18 | Cottingham John A (SVP, Gen Counsel & Secretary) | Option Exercise | 10,000 | 56.86 | 568,600 |
| 2007-10-15 | Hoffmeister David F (Chief Financial Officer) | Option Exercise | 50,000 | .00 | 0 |
| 2007-10-05 | Brust Bernd (SVP - Worldwide Sales) | Sale | 1,250 | 84.00 | 105,000 |
| 2007-10-05 | Brust Bernd (SVP - Worldwide Sales) | Option Exercise | 1,250 | 64.51 | 80,637 |
| 2007-09-06 | Barthelemy Nicolas (SVP, Cell Culture Systems) | Option Exercise | 1,421 | 70.34 | 99,953 |
| 2007-09-05 | Cottingham John A (SVP, Gen Counsel & Secretary) | Sale | 11,500 | 80.00 | 920,000 |
| 2007-09-05 | Cottingham John A (SVP, Gen Counsel & Secretary) | Option Exercise | 11,500 | 40.08 | 460,862 |
| 2007-09-05 | Thompson John D (SVP, Corporate Development) | Sale | 27,813 | 80.00 | 2,225,040 |
| 2007-09-04 | Benchimol Claude (SVP, Research & Development) | Option Exercise | 12,500 | .00 | 0 |
| 2007-08-24 | Richard Kelli (Chief Accounting Officer) | Sale | 937 | 78.43 | 73,488 |
| 2007-08-17 | Uprichard David C (Director) | Option Exercise | 400 | 72.36 | 28,944 |
| 2007-08-06 | Brust Bernd (SVP - Worldwide Sales) | Sale | 16,250 | 78.37 | 1,273,501 |
| 2007-07-20 | Short Jay M Phd (Director) | Option Exercise | 2,000 | 3.80 | 7,600 |
| 2007-07-10 | Barthelemy Nicolas (SVP, Cell Culture Systems) | Sale | 7,250 | 75.00 | 543,750 |
| 2007-06-15 | Barthelemy Nicolas (SVP, Cell Culture Systems) | Sale | 3,250 | 75.00 | 243,750 |
| 2007-06-15 | Barthelemy Nicolas (SVP, Cell Culture Systems) | Option Exercise | 3,250 | 62.51 | 203,157 |
| 2007-06-15 | Uprichard David C (Director) | Sale | 500 | 74.53 | 37,265 |
| 2007-06-13 | Cottingham John A (SVP, Gen Counsel & Secretary) | Sale | 19,635 | 74.01 | 1,453,186 |
| 2007-06-13 | Cottingham John A (SVP, Gen Counsel & Secretary) | Option Exercise | 14,300 | 34.51 | 493,493 |
| 2007-06-11 | Barthelemy Nicolas (SVP, Cell Culture Systems) | Sale | 437 | 74.00 | 32,338 |
| 2007-05-15 | Barthelemy Nicolas (SVP Cell Culture Systems) | Sale | 1,617 | 71.84 | 116,173 |
| 2007-05-14 | Benchimol Claude (SVP R&D) | Option Exercise | 2,500 | .00 | 0 |
| 2007-05-14 | Cottingham John A (SVP General Counsel & Sec.) | Option Exercise | 2,500 | .00 | 0 |
| 2007-05-14 | Thompson John D (SVP Corporate Development) | Option Exercise | 2,500 | .00 | 0 |
| 2007-05-12 | Lucier Gregory T (Chairman & CEO) | Option Exercise | 9,000 | .00 | 0 |
| 2007-02-28 | Radak John Matthew (VP Finance & Accounting) | Sale | 761 | 64.28 | 48,917 |
| 2007-02-28 | Radak John Matthew (VP Finance & Accounting) | Option Exercise | 761 | 29.70 | 22,601 |
| 2007-02-22 | Lorimier Bradley G (Director) | Sale | 5,900 | 66.20 | 390,580 |
| 2007-02-22 | Lorimier Bradley G (Director) | Option Exercise | 10,000 | 12.00 | 120,000 |
| 2007-02-14 | Bulkley Benjamin (Sr. VP Global Commercial Ops) | Sale | 98,374 | 66.18 | 6,510,086 |
| 2007-02-14 | Bulkley Benjamin (Sr. VP Global Commercial Ops) | Option Exercise | 98,374 | 62.59 | 6,157,392 |
| 2006-08-15 | Uprichard David C (Director) | Purchase | 100 | 59.85 | 5,985 |
| 2006-08-11 | Uprichard David C (Director) | Purchase | 200 | 58.97 | 11,794 |
| 2006-08-10 | Uprichard David C (Director) | Purchase | 200 | 58.60 | 11,720 |
| 2006-08-10 | Reynolds W Ann (Director) | Purchase | 808 | 58.20 | 47,025 |
| 2006-08-07 | Barthelemy Nicolas (SVP BioProduction Sys & Svcs) | Purchase | 2,700 | 56.24 | 151,848 |
| 2006-06-06 | Uprichard David C (Director) | Purchase | 100 | 63.26 | 6,326 |
| 2006-05-30 | Lucier Gregory T (Chairman & CEO) | Purchase | 1,000 | 64.18 | 64,180 |
| 2006-05-26 | Lucier Gregory T (Chairman & CEO) | Purchase | 2,000 | 64.10 | 128,199 |
| 2006-05-15 | Radak John Matthew (VP Finance & Accounting) | Sale | 394 | 67.05 | 26,417 |
| 2006-03-13 | Barthelemy Nicolas (Svp) | Sale | 5,000 | 69.73 | 348,634 |
| 2005-11-16 | Hoffmeister David F (Chief Financial Officer) | Purchase | 1,530 | 65.02 | 99,485 |
| 2005-08-05 | Radak John Matthew (Accounting) | Sale | 262 | 85.43 | 22,382 |
| 2005-05-31 | Lucier Gregory T (CEO) | Sale | 16,613 | 79.43 | 1,319,520 |
| 2005-05-18 | Grimm Donald W (Director) | Sale | 9,000 | 79.00 | 711,000 |
| 2005-05-18 | Grimm Donald W (Director) | Option Exercise | 10,000 | 12.00 | 120,000 |
| 2005-03-11 | Uprichard David C (Director) | Purchase | 500 | 71.08 | 35,540 |
| 2005-03-09 | Uprichard David C (Director) | Purchase | 500 | 71.08 | 35,540 |
| 2005-02-23 | Reynolds W Ann (Director) | Purchase | 1,200 | 68.74 | 82,488 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of INVITROGEN CORP (symbol IVGN,
CIK number 1073431) see
the Securities and Exchange Commission (SEC) website.
|
|
